CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's Free Cash Flow Growth by Quarter and Year

Atara Biotherapeutics,'s Free Cash Flow results by quarter and year




ATRA Free Cash Flow (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - -24.94 -36.75 -12.91
III Quarter September -48.10 -20.23 -11.54 -6.24
II Quarter June -39.43 -20.30 -12.49 -6.62
I Quarter March -34.82 -22.03 -11.66 -
FY   -122.35 -87.50 -72.44 -25.77



ATRA Free Cash Flow third quarter 2018 Y/Y Growth Comment
Atara Biotherapeutics, Inc. in the third quarter recorded free cash outflow of $ -48.10 millions.

According to the results reported in the third quarter, Atara Biotherapeutics, Inc. achieved the best Free Cash Flow growth in Biotechnology & Drugs industry. While Atara Biotherapeutics, Inc.' s Free Cash Flow no change of % ranks overall at the positon no. in the third quarter.




ATRA Free Cash Flow ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics,'s third quarter 2018 Free Cash Flow $ 0.00 millions ATRA's Income Statement
Atara Biotherapeutics,'s third quarter 2017 Free Cash Flow $ 0.00 millions Quarterly ATRA's Income Statement
New: More ATRA's historic Free Cash Flow Growth >>


ATRA Free Cash Flow (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Atara Biotherapeutics,'s Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's III. Quarter Q/Q Free Cash Flow Comment
III. Quarter 2018 free cash outflow of -48.10 millions by Atara Biotherapeutics, Inc. look even worse if you take a look at free cash outflow -39.43 millions in the previous quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential Free Cash Flow growth. While Atara Biotherapeutics,'s Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's III. Quarter Q/Q Free Cash Flow Comment
III. Quarter 2018 accomplishment of -48.10 millions by Atara Biotherapeutics, Inc. look even worse if you take a look at -39.43 millions a quarter before.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential Free Cash Flow growth. While Atara Biotherapeutics,'s Free Cash Flow growth quarter on quarter, overall rank is .


Atara Biotherapeutics,'s 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
Cumulative Free Cash Flow 12 Months Ending $ -105.84 $ -76.28 $ -61.46 $ -67.27 $ -87.39
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
Atara Biotherapeutics, Inc.' has realized cumulative trailing twelve months free cash outflow of $ -106 millions in the Sep 30 2018 period.
The results are detiriorating as the cumulative free cash outflow is becoming larger from $ -76.28 millions in the twelve months ending a quarter before and $ -39.43 millions from the TTM period ending Sep 30 2017.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
Atara Biotherapeutics, Inc.' has realized cumulative trailing twelve months free cash outflow of $ -106 millions in the Sep 30 2018 period.
The results are detiriorating as the cumulative free cash outflow is inflating from $ -76.28 millions in TTM ending quarter Jun 30 2018 and $ -39.43 millions from the TTM period ending Sep 30 2017.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Biotechnology & Drugs Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
ATRA's Free Cash Flow Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for ATRA's Competitors
Free Cash Flow Growth for Atara Biotherapeutics,'s Suppliers
Free Cash Flow Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Sep 30 2018 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Sep 30 2018
Strata Skin Sciences, Inc.  239.34 %$ 239.344 millions
Universal Hospital Services Inc  236.11 %$ 236.106 millions
Genomic Health Inc  210.75 %$ 210.750 millions
Community Health Systems Inc  203.51 %$ 203.509 millions
Lhc Group, Inc  199.36 %$ 199.360 millions
Cryolife Inc  196.72 %$ 196.719 millions
Msa Safety Incorporated  181.20 %$ 181.201 millions
Staar Surgical Co  167.68 %$ 167.678 millions
Acorda Therapeutics Inc  161.59 %$ 161.588 millions
Infusystem Holdings, Inc  146.26 %$ 146.256 millions
Heska Corp  129.66 %$ 129.660 millions
Vertex Pharmaceuticals Inc  124.21 %$ 124.209 millions
Amphastar Pharmaceuticals, Inc.  123.97 %$ 123.971 millions
U.s. Neurosurgical Holdings, Inc.  110.39 %$ 110.390 millions
Jrsis Health Care Corp  106.58 %$ 106.584 millions
Masimo Corp  106.55 %$ 106.545 millions
Regeneron Pharmaceuticals Inc  104.31 %$ 104.306 millions
Hill-rom Holdings, Inc.  103.64 %$ 103.641 millions
Quest Diagnostics Inc  100.28 %$ 100.276 millions
Boston Scientific Corporation  96.47 %$ 96.471 millions
Natus Medical Inc  93.95 %$ 93.950 millions
Lilly Eli & Co  93.47 %$ 93.467 millions
Tabula Rasa Healthcare, Inc.  84.97 %$ 84.971 millions
Bruker Corp  80.17 %$ 80.170 millions
Djo Finance Llc  78.59 %$ 78.589 millions
Universal Health Services Inc  77.40 %$ 77.396 millions
Celgene Corp  76.84 %$ 76.838 millions
Pacific Health Care Organization Inc  76.19 %$ 76.189 millions
Integra Lifesciences Holdings Corp  75.17 %$ 75.171 millions
China Health Industries Holdings, Inc.  73.19 %$ 73.194 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CRM's Profile

Stock Price

CRM's Financials

Business Description

Fundamentals

Charts & Quotes

CRM's News

Suppliers

CRM's Competitors

Customers & Markets

Economic Indicators

CRM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071